ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/02/24 | 1,509 | 1,516 | 1,455 | 1,485 | -25 | -1.7% | 420,500 |
| 2023/02/22 | 1,512 | 1,523 | 1,487 | 1,510 | -21 | -1.4% | 440,600 |
| 2023/02/21 | 1,557 | 1,559 | 1,523 | 1,531 | -26 | -1.7% | 239,300 |
| 2023/02/20 | 1,557 | 1,574 | 1,530 | 1,557 | ±0 | ±0% | 269,800 |
| 2023/02/17 | 1,581 | 1,587 | 1,553 | 1,557 | -42 | -2.6% | 277,700 |
| 2023/02/16 | 1,610 | 1,617 | 1,582 | 1,599 | +2 | +0.1% | 279,700 |
| 2023/02/15 | 1,620 | 1,620 | 1,583 | 1,597 | -15 | -0.9% | 224,400 |
| 2023/02/14 | 1,620 | 1,628 | 1,585 | 1,612 | +14 | +0.9% | 238,000 |
| 2023/02/13 | 1,615 | 1,615 | 1,583 | 1,598 | -43 | -2.6% | 305,900 |
| 2023/02/10 | 1,628 | 1,642 | 1,612 | 1,641 | -16 | -1% | 318,200 |
| 2023/02/09 | 1,646 | 1,660 | 1,617 | 1,657 | -18 | -1.1% | 416,300 |
| 2023/02/08 | 1,711 | 1,715 | 1,659 | 1,675 | -5 | -0.3% | 297,300 |
| 2023/02/07 | 1,735 | 1,735 | 1,659 | 1,680 | -61 | -3.5% | 590,800 |
| 2023/02/06 | 1,678 | 1,748 | 1,659 | 1,741 | +143 | +8.9% | 958,000 |
| 2023/02/03 | 1,653 | 1,654 | 1,587 | 1,598 | -47 | -2.9% | 307,600 |
| 2023/02/02 | 1,648 | 1,664 | 1,627 | 1,645 | +9 | +0.6% | 393,400 |
| 2023/02/01 | 1,635 | 1,680 | 1,615 | 1,636 | +41 | +2.6% | 552,100 |
| 2023/01/31 | 1,593 | 1,615 | 1,586 | 1,595 | -15 | -0.9% | 381,500 |
| 2023/01/30 | 1,624 | 1,628 | 1,597 | 1,610 | -22 | -1.3% | 309,100 |
| 2023/01/27 | 1,675 | 1,677 | 1,626 | 1,632 | -43 | -2.6% | 303,600 |
| 2023/01/26 | 1,674 | 1,691 | 1,665 | 1,675 | -12 | -0.7% | 298,500 |
| 2023/01/25 | 1,689 | 1,699 | 1,661 | 1,687 | -12 | -0.7% | 473,700 |
| 2023/01/24 | 1,647 | 1,730 | 1,634 | 1,699 | +91 | +5.7% | 789,800 |
| 2023/01/23 | 1,583 | 1,610 | 1,571 | 1,608 | +58 | +3.7% | 456,300 |
| 2023/01/20 | 1,544 | 1,553 | 1,526 | 1,550 | +5 | +0.3% | 247,500 |
| 2023/01/19 | 1,530 | 1,558 | 1,516 | 1,545 | -2 | -0.1% | 223,100 |
| 2023/01/18 | 1,495 | 1,550 | 1,495 | 1,547 | +64 | +4.3% | 295,300 |
| 2023/01/17 | 1,494 | 1,502 | 1,478 | 1,483 | -20 | -1.3% | 198,000 |
| 2023/01/16 | 1,488 | 1,513 | 1,487 | 1,503 | -5 | -0.3% | 188,800 |
| 2023/01/13 | 1,527 | 1,540 | 1,494 | 1,508 | -32 | -2.1% | 292,100 |
| 2023/01/12 | 1,557 | 1,587 | 1,524 | 1,540 | +5 | +0.3% | 274,000 |
| 2023/01/11 | 1,502 | 1,558 | 1,500 | 1,535 | +42 | +2.8% | 392,800 |
| 2023/01/10 | 1,550 | 1,569 | 1,486 | 1,493 | -51 | -3.3% | 382,300 |
| 2023/01/06 | 1,521 | 1,554 | 1,521 | 1,544 | +14 | +0.9% | 364,800 |
| 2023/01/05 | 1,580 | 1,582 | 1,527 | 1,530 | -54 | -3.4% | 375,200 |
| 2023/01/04 | 1,676 | 1,676 | 1,580 | 1,584 | -97 | -5.8% | 322,400 |
| 2022/12/30 | 1,691 | 1,703 | 1,680 | 1,681 | +3 | +0.2% | 175,500 |
| 2022/12/29 | 1,679 | 1,688 | 1,652 | 1,678 | +1 | +0.1% | 238,000 |
| 2022/12/28 | 1,655 | 1,688 | 1,636 | 1,677 | +9 | +0.5% | 278,700 |
| 2022/12/27 | 1,638 | 1,668 | 1,637 | 1,668 | +47 | +2.9% | 311,100 |
| 2022/12/26 | 1,659 | 1,668 | 1,616 | 1,621 | -40 | -2.4% | 271,800 |
| 2022/12/23 | 1,665 | 1,671 | 1,641 | 1,661 | -20 | -1.2% | 290,300 |
| 2022/12/22 | 1,695 | 1,698 | 1,674 | 1,681 | -8 | -0.5% | 249,300 |
| 2022/12/21 | 1,695 | 1,707 | 1,672 | 1,689 | -18 | -1.1% | 312,100 |
| 2022/12/20 | 1,776 | 1,780 | 1,693 | 1,707 | -71 | -4% | 355,700 |
| 2022/12/19 | 1,791 | 1,797 | 1,770 | 1,778 | -23 | -1.3% | 265,400 |
| 2022/12/16 | 1,805 | 1,812 | 1,787 | 1,801 | -29 | -1.6% | 385,300 |
| 2022/12/15 | 1,875 | 1,883 | 1,829 | 1,830 | -50 | -2.7% | 300,000 |
| 2022/12/14 | 1,857 | 1,904 | 1,850 | 1,880 | +39 | +2.1% | 406,000 |
| 2022/12/13 | 1,885 | 1,898 | 1,834 | 1,841 | -44 | -2.3% | 396,600 |
301～
350
件表示中 / 6711件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 62,200円 | -3.7% | -36.7% | 3.22% | 20.98倍 | 1.40倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ゼリア新薬 | 200,900円 | +9.6% | +17.5% | 2.29% | 11.35倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 214,700円 | +7.6% | +57.5% | 2.47% | 16.58倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 227,700円 | +0.3% | +2.7% | 2.20% | 12.90倍 | 1.04倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 78,400円 | +10.5% | +169.1% | 3.83% | 12.40倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
